Monash IVF Group Limited (ASX:MVF)
Australia
· Delayed Price · Currency is AUD 0.730
-0.010 (-1.35%)
Apr 29, 2026, 4:10 PM AEST
Monash IVF Group Revenue
Monash IVF Group had revenue of 137.86M AUD in the half year ending December 31, 2025, with 9.57% growth. This brings the company's revenue in the last twelve months to 269.39M, down -0.15% year-over-year. In the fiscal year ending June 30, 2025, Monash IVF Group had annual revenue of 271.92M with 6.54% growth.
Revenue (ttm)
269.39M
Revenue Growth
-0.15%
P/S Ratio
1.06
Revenue / Employee
302.01K
Employees
892
Market Cap
284.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 271.92M | 16.69M | 6.54% |
| Jun 30, 2024 | 255.23M | 41.43M | 19.38% |
| Jun 30, 2023 | 213.80M | 21.50M | 11.18% |
| Jun 30, 2022 | 192.29M | 8.69M | 4.73% |
| Jun 30, 2021 | 183.61M | 38.19M | 26.26% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Australian Clinical Labs | 737.49M |
| Healius | 1.37B |
| Integral Diagnostics | 767.82M |
| Rhythm Biosciences | 1.65M |
| Cryosite | 15.75M |
| INOVIQ | 2.10M |
| Microba Life Sciences | 14.90M |
| Genetic Signatures | 19.94M |